Navigation Links
BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
Date:7/10/2008

re funding of the peramivir program, that ongoing peramivir clinical trials may not be successful, that the peramivir program may not be successful, that the pivotal trial with forodesine HCl in cutaneous T-cell lymphoma (CTCL) may not meet its endpoint, that the Phase II trial of BCX-4208 for psoriasis may not be successfully completed, that development and commercialization of forodesine HCl in CTCL may not be successful, that we or our licensees may not be able to enroll the required number of subjects in planned clinical trials of our product candidates and that such clinical trials may not be successfully completed, that BioCryst or its licensees may not commence as expected additional human clinical trials with our product candidates, that our product candidates may not receive required regulatory clearances from the FDA, that ongoing and future preclinical and clinical development may not have positive results, that we or our licensees may not be able to continue future development of our current and future development programs, that our development programs may never result in future product, license or royalty payments being received by BioCryst, that BioCryst may not be able to retain its current pharmaceutical and biotechnology partners for further development of its product candidates or it may not reach favorable agreements with potential pharmaceutical and biotechnology partners for further development of its product candidates, that our projected burn rate may not be consistent with our expectations, that BioCryst may not have sufficient cash to continue funding the development, manufacturing, marketing or distribution of its products and that additional funding, if necessary, may not be available at all or on terms acceptable to BioCryst. Please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst's most recent Annual Report on Form 10-K, most recent Registration Statement on Form S-3 (
'/>"/>
SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
2. BioCryst Provides Forodesine HCl Update
3. BioCryst Updates Peramivir Clinical Development Plan
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , Dec. 15, 2014  Stephen Squires, CEO ... Quantum Materials Corp (OTCQB:QTMM), will be speaking ... Quantum Materials (RCQM) on December 16th, 2014. The RCQM ... exotic nanomaterials in attracting top faculty and students and ... collaborate on research. "We have a ...
(Date:12/13/2014)... , Dec. 11, 2014 Research and Markets ... addition of the "Drug Injection Devices to ... http://photos.prnewswire.com/prnh/20130307/600769 As ... an expanding list of health conditions, drug developers ... simplify the administration process and increase the efficiency ...
(Date:12/13/2014)... DUBLIN , December 12, 2014 /PRNewswire/ ... ) has announced the addition of the  ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... dioxide (CO2) in the respiratory gasses during ... respiratory care. Capnography provides information about CO2 ...
Breaking Medicine Technology:Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4Global Capnography Market 2015-2019: Key Vendors are Covidien, Masimo, Philips Healthcare, Smiths Medical and Welch Allyn 2Global Capnography Market 2015-2019: Key Vendors are Covidien, Masimo, Philips Healthcare, Smiths Medical and Welch Allyn 3
... PRGO ; TASE) today announced that it ... of the assets of CanAm Care, a privately-held, Alpharetta, ... million in cash. The acquisition is expected to be ... The assets acquired from CanAm Care include: Dex4® hypoglycemia ...
... 2012 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... devices worldwide, today announced updates on new product launches for ... in 2012. N ew product ... new products, exceeding its product development goals outlined at the ...
Cached Medicine Technology:Perrigo Acquires Assets of CanAm Care for $36 Million 2Perrigo Acquires Assets of CanAm Care for $36 Million 3Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline 2Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline 3Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline 4
(Date:12/15/2014)... December 15, 2014 Main Street Dental ... is weighing in on a new study providing evidence ... the oral hygiene of children. , Sufficient enough evidence ... such as pop or juice drinks, with the onset ... however, is whether drinks listed as 100% fruit juice, ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 OutMarket ... today released “ Social Media Cheat Sheets ,” a ... community that drives results on the top ten social ... program. It helps drive awareness, engagement, and customer service. ... marketers to make an impact on new networks and ...
(Date:12/15/2014)... 14, 2014 (HealthDay News) -- Expert pilots process visual ... why they make better decisions during landings, a new ... difficult techniques for pilots to master, and 36 percent ... crashes occur during final approach and landing. Researchers ... 12 moderately experienced pilots while they were at the ...
(Date:12/15/2014)... Emergo Group, Inc., a medical device regulatory consulting ... South America, Europe, the Middle East, Asia and Australia, ... 2015 Medical Device Industry Survey. Each year, Emergo conducts ... market trends as well as regulatory and operational concerns ... , Overall prospects for medical device ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Bacteroides is becoming ... only is it much more prevalent than coliforms, it cannot ... in the environment. , Key Benefits of the new ... fecal contamination , Eliminates false positives from coliforms ... and Sensitivity , Maintain the same sampling ...
Breaking Medicine News(10 mins):Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2
... new score for predicting a person,s risk of heart ... the existing test and should be recommended for use ... Health and Clinical Excellence (NICE). The University of ... through the not-for-profit partnership QResearch, to develop the ground-breaking ...
... , ... Direct Product Evaluations and In-depth, Confidential Interviews Conducted by KLAS with Healthcare Executives and ... Market Segment. , ... Calabasas, CA (PRWEB) July 8, 2009 -- RES-Q® Healthcare Systems announced that its RES-Q ...
... Physician ... , ... July 8, 2009 -- Physician recruiting firm LocumTenens.com has announced its expansion ... specialties often referred to collectively as primary care. Traditionally a niche agency specializing ...
... TORONTO, July 8 Dyadem today announced that its ... finalist in the Information Technology category for Ernst & ... awards recognize individuals who demonstrate the entrepreneurial spirit, and ... ability to grow their businesses in the face of ...
... and the recently introduced Lindi(R) Face Wash, have been awarded ... Manufacturers and Distributors Association (ICMAD) at the sixth annual ... New York City on June 11, 2009. , ... within the beauty and personal care markets and Lindi Skin ...
... , , BETHESDA, Md., July 8 ... Care (IPC) solutions, today announced that it has expanded ... new hospital deployments and recently signed multi-year agreements to ... PatientLife System (R) . , , ...
Cached Medicine News:Health News:New heart disease risk score outperforms existing test 2Health News:RES-Q Labor Resource Management Scores the Highest Among Staff/Nurse Scheduling System Solutions Analyzed in the 2009 KLAS Mid-term Performance Review 2Health News:LocumTenens.com Expands Service Lines to Include Primary Care 2Health News:LocumTenens.com Expands Service Lines to Include Primary Care 3Health News:Dyadem CEO Kevin North Named a Finalist in Ernst & Young's 2009 Entrepreneur Of The Year Awards 2Health News:Dyadem CEO Kevin North Named a Finalist in Ernst & Young's 2009 Entrepreneur Of The Year Awards 3Health News:Skincare Industry Newcomer Shines 2Health News:GetWellNetwork Continues Growth with Eleven New Hospital Launches and Contract Signings 2Health News:GetWellNetwork Continues Growth with Eleven New Hospital Launches and Contract Signings 3
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 L reference mark make it ideal for low volume pipetting....
... The MonoPrep LBP Processor is a ... cytology specimen collection, accessioning, processing, sampling, and ... state-of-the-art data management. The MonoPrep LBP Processor ... layers from a broad range of cytology ...
... Binding, Graduated Pipet Tips - 2l - 200l. ... referenced. Produced & packaged completely by automation. RNAse ... packaged 96 tips/rack and 10 racks/cs. AVR2 is ... racks/cs. AVR3 is the Stacked Rack packaged 96 ...
... ART Aerosol Resistant Tips offer a ... ART Tips are designed for applications such ... studies. In addition, ART Tips are excellent ... and forensic studies. ART Tips prevent aerosol ...
Medicine Products: